Increased Polypharmacy in SLE Patients A cross-sectional study of US adults with systemic lupus erythematosus (SLE) shows significantly increased prevalence of polypharmacy, related to age, disease outcomes and often, non-SLE common medications. https://t.co/3Mo3O8Ra04 https://t.co/zRS8TmFvvf